Diabetes: Types | eHealth News

FDA Approves First Biosimilar Insulin Product

HealthDay.com - Jul 29, 2021 0

Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option

Diabetes that follows pancreatic disease is frequently classified as type 2 diabetes but is associated with worse glycemic control and higher use of insulin within five years than type 2 diabetes

Diabetes of Exocrine Pancreas Often Classified as T2DM

HealthDay.com - Oct 30, 2017 0

Worse glycemic control, more insulin use for diabetes following pancreatic disease than type 2 diabetes

Archives